| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.42B | 25.74B | 25.45B | 22.71B | 23.33B | 22.36B |
| Gross Profit | 7.34B | 6.95B | 7.50B | 6.88B | 8.09B | 8.29B |
| EBITDA | 9.59B | 8.76B | 9.47B | 8.59B | 9.29B | 10.26B |
| Net Income | 2.73B | 2.20B | 1.88B | 1.84B | 3.46B | 4.30B |
Balance Sheet | ||||||
| Total Assets | 58.84B | 58.17B | 54.85B | 52.51B | 51.09B | 48.02B |
| Cash, Cash Equivalents and Short-Term Investments | 4.02B | 4.05B | 3.92B | 5.97B | 8.15B | 8.07B |
| Total Debt | 10.40B | 11.50B | 9.74B | 10.20B | 10.95B | 9.77B |
| Total Liabilities | 27.33B | 27.40B | 26.07B | 25.20B | 26.22B | 25.00B |
| Stockholders Equity | 19.50B | 18.90B | 17.58B | 16.69B | 15.55B | 13.98B |
Cash Flow | ||||||
| Free Cash Flow | 6.25B | 1.12B | 2.35B | 455.00M | 1.67B | 5.60B |
| Operating Cash Flow | 6.05B | 5.61B | 7.16B | 5.28B | 5.14B | 7.71B |
| Investing Cash Flow | -4.28B | -4.47B | -5.03B | -4.96B | -3.25B | -1.78B |
| Financing Cash Flow | -2.56B | -1.88B | -3.28B | -2.65B | -1.81B | -1.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $114.64B | 9.00 | 25.22% | 0.95% | 25.14% | 73.19% | |
74 Outperform | $145.25B | 22.35 | 45.96% | 2.07% | 21.70% | 36.79% | |
69 Neutral | $175.47B | 6.00 | 16.59% | 4.60% | 7.59% | -13.66% | |
66 Neutral | $68.12B | 8.97 | 7.68% | 10.04% | 4.64% | -51.66% | |
64 Neutral | $87.50B | 24.09 | 14.52% | 1.25% | 5.35% | 55.07% | |
63 Neutral | $46.47B | 17.20 | 5.35% | 1.03% | -1.31% | 149.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |